No photo of Chong-Xian Pan

View Scopus Profile

Chong-Xian Pan, MD; PhD

Professor

  • 3350 Citations
  • 32 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chong-Xian Pan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Targeted- and timed-releasing nanotherapeutics against leukemia stem cells

Pan, C.

National Institutes of Health

4/15/15 → 3/31/20

Project: Research project

    • Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer

    Pan, C.

    Project: Research project

    University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities

    Chen, M., Chen, M., deVere White, R. W., Rocke, D. M., Pan, C. & Lloyd, K. C.

    Project: Research project

    Development of targeting nanotherapeutics against bladder cancer

    Pan, C.

    National Institutes of Health

    10/1/13 → 9/30/17

    Project: Research project

    • Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis

    Lara, P. N. & Pan, C.

    National Institutes of Health

    8/1/11 → 7/31/16

    Project: Research project

    • Research Output

    • 3350 Citations
    • 32 h-Index
    • 88 Article
    • 1 Chapter
    • 1 Review article

    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

    Petrylak, D. P., de Wit, R., Chi, K. N., Drakaki, A., Sternberg, C. N., Nishiyama, H., Castellano, D., Hussain, S. A., Fléchon, A., Bamias, A., Yu, E. Y., van der Heijden, M. S., Matsubara, N., Alekseev, B., Necchi, A., Géczi, L., Ou, Y. C., Coskun, H. S., Su, W. P., Bedke, J. & 126 others, Gakis, G., Percent, I. J., Lee, J. L., Tucci, M., Semenov, A., Laestadius, F., Peer, A., Tortora, G., Safina, S., Garcia del Muro, X., Rodriguez-Vida, A., Cicin, I., Harputluoglu, H., Tagawa, S. T., Vaishampayan, U., Aragon-Ching, J. B., Hamid, O., Liepa, A. M., Wijayawardana, S., Russo, F., Walgren, R. A., Zimmermann, A. H., Hozak, R. R., Bell-McGuinn, K. M., Powles, T., Wong, S. L. S., Tan, T. H., Hovey, E. J., Clay, T. D., Wan Ng, S. S., Rutten, A., Machiels, J. P., Dumez, H., Cheng, S. Y. S., Ferrario, C., Sengeloev, L., Jensen, N. V., Thibault, C., Laguerre, B., Joly, F., Culine, S., Becht, C., Niegisch, G., Stöckle, M., Grimm, M. O., Schwentner, C. A., Schultze-Seemann, W., Kalofonos, H., Mavroudis, D., Papandreou, C., Karavasilis, V., Révész, J., Rosenbaum, E., Leibowitz-Amit, R., Kejzman, D., Sarid, D., Scagliotti, G. V., Bracarda, S., Massari, F., Osawa, T., Miyajima, N., Shinohara, N., Fukuta, F., Ohyama, C., Obara, W., Yamashita, S., Tomita, Y., Kawai, K., Fukasawa, S., Oyama, M., Yonese, J., Nagata, M., Uemura, M., Nishimura, K., Kawakita, M., Tsunemori, H., Hashine, K., Inokuchi, J., Yokomizo, A., Nagamori, S., Lee, H. J., Park, S. H., Rha, S. Y., Kim, Y. J., Lee, Y. G., Vazquez Cortés, L., Lorena Urzua Flores, C., Blaisse, R. J. B., Erdkamp, F. L. G., Aarts, M. J. B., Wojcik-Tomaszewska, J., Tomczak, P., Sikora-Kupis, B., Schenker, M., Herzal, A. A., Udrea, A. A., Karlov, P., Fomkin, R., Gajate Borau, P., Grande, E., Delgado Mignorance, J. I., Su, Y. L., Li, J. R., Lin, C. L., Lin, C. C., Yeh, S. P., Erman, M., Urun, Y., Golovko, Y., Bondarenko, I., Sinielnikov, I., Crabb, S. J., Syndikus, I., Huddart, R., Sundar, S., Chowdhury, S., Sarwar, N., Flaig, T. W., Pan, C. X., Schwarz, J. K., Cultrera, J. L., Acs, P. I., Hainsworth, J. D., Herms, B. T., Lawler, W. E. & Lowe, T. E., Jan 2020, In : The Lancet Oncology. 21, 1, p. 105-120 16 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia

    Lin, T-Y., Zhu, Y., Li, Y., Zhang, H., Ma, A. H., Long, Q., Keck, J., Lam, K., Pan, C-X. & Jonas, B., Aug 1 2019, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 20, 102004.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Fidelity of a PDX-CR model for bladder cancer

    Mondal, A. M., Ma, A. H., Li, G., Krawczyk, E., Yuan, R., Lu, J., Schlegel, R., Stamatakis, L., Kowalczyk, K. J., Philips, G. K., Pan, C-X. & Liu, X., Jan 1 2019, In : Biochemical and Biophysical Research Communications.

    Research output: Contribution to journal › Article

    • Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice

    Martin, K. A., Hum, N. R., Sebastian, A., He, W., Siddiqui, S., Ghosh, P. M., Pan, C. X., de Vere White, R. & Loots, G. G., Oct 9 2019, In : International journal of molecular sciences. 20, 20

    Research output: Contribution to journal › Article

    Open Access

    • Radiocarbon tracers in toxicology and medicine: Recent advances in technology and science

    Malfatti, M. A., Buchholz, B. A., Enright, H. A., Stewart, B. J., Ognibene, T. J., McCartt, A. D., Loots, G. G., Zimmermann, M., Scharadin, T. M., Cimino, G. D., Jonas, B. A., Pan, C. X., Bench, G., Henderson, P. T. & Turteltaub, K. W., Jan 1 2019, In : Toxics. 7, 2, 27.

    Research output: Contribution to journal › Review article

    Open Access